Global Umbilical Cord Blood Banking Market Size Likely to Grow at a CAGR of 11.7% By 2034

Market Size and Growth

As per the Umbilical Cord Blood Banking Market size analysis conducted by the CMI Team, the global Umbilical cord blood banking Market is expected to record a CAGR of 11.7% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 19.13 Billion. By 2034, the valuation is anticipated to reach USD 51.67 Billion.

Overview

According to industry experts at CMI, the Umbilical Cord Blood Banking Market is expanding rapidly, owing to the rising stem cell or regenerative medicine awareness and improved technologies for preserving stem cells. Major players such as Cryo-Cell International, Cord Blood Registry, and ViaCord are spending on superior processing and storage in order to increase cell viability and safety.

High healthcare infrastructure and an increase in demand for customized therapies drive the growth of the healthcare sector in North America. European markets place priorities on regulations and good moral practices, which are in line with sustainable healthcare prospects. The use is high in Asia-Pacific, where penetration occurs due to an increase in births, government funding, and growth in the private healthcare industries. Partnerships between biotech companies, hospitals, and research organizations expedite innovation and market expansion in the world market.

Key Trends & Drivers

The Rising Prevalence of Genetic and Chronic Conditions:The rise of immune disorders, lymphoma, leukemia, thalassemia, and any other genetic disorder worldwide has been contributing directly to the uptake of stem cell therapies and thus driving the umbilical cord blood banking demand for regenerative and personal medical remedies.

Developments in Stem Cell Technology and Therapy: Consistent research and development in the area of stem cell applications, such as regenerative medicine and tissue engineering, as well as treatment of neurological disorders, is a factor that is increasing the clinical utility of cord blood, thereby incentivizing more parents to store cord blood.

Government and Regulatory Assistance: Government programs that encourage the use of cord blood by the population, along with the establishment of favorable regulatory environments and tax benefits in a number of economies, are contributing to the rise of awareness, availability, and infrastructural development of public cord blood banking in both the developed and the emerging economies.

Report Scope

SWOT Analysis

• Strength: The benefit of banking umbilical cord blood, finding an alternative to the challenging method of bone marrow transplant, is that it can be a source of hematopoietic stem cells that are not as invasive and are ethically viable. High technology increases the cell viability, and the increased awareness of the consumers regarding regenerative medicine and personalized therapies increases demand. Market development is encouraged by good healthcare infrastructure in the developed regions.

• Weakness: Collection, processing, and long-term storage are costly, which makes it limited in areas where the economies are developing. Market fragmentation is caused by the absence of uniform rules and awareness among individuals on the same. Besides, there are doubts as to the efficiency and limited use of stored cord blood cells as a product, which will be a deterrence to certain consumers.

• Opportunity: The growth in rates of genetic and chronic illnesses opens up opportunities in the need for stem cell therapy. New possibilities are created through progress in regeneration medicine and tissue engineering. The expansion of governmental efforts and the public-private partnerships, primarily in the emerging markets, provide the growth opportunity. Innovation in technology that involves automation of processing has the capability of enhancing efficiency and decreasing the costs.

• Threat: High regulatory regimes and ethical issues may slow down the approvals and reduce market expansion. The threat of competition due to other sources of stem cells e.g. induced pluripotent stem cells (iPSCs), is a threat. The privacy and protection of data on patient information might be a setback to consumer confidence and acceptance.

List of the prominent players in the Umbilical Cord Blood Banking Market:

• Cord Blood Registry (CBR)
• Cryo-Cell International
• ViaCord
• LifeCell International
• Global Cord Blood Corporation
• StemCyte
• Cryo-Save
• Americord Registry
• Smart Cells
• CordVida
• Cells4Life
• FamiCord Group
• AlphaCord
• Singapore Cord Blood Bank
• Canadian Blood Services
• Others

The Umbilical Cord Blood Banking Market is segmented as follows:

By Storage Type

• Public Cord Blood Banks
• Private Cord Blood Banks

By Application

• Cancer Treatment
• Blood Disorders
• Metabolic Disorders
• Immune Disorders
• Others

By Service Provider

• Hospitals
• Pharmaceutical & Biotech Companies
• Research Institutes
• Specialty Clinics

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America